第二支内乳动脉原位与游离移植的远期结局比较
该研究在2600例双侧内乳动脉搭桥患者中,比较第二支内乳动脉作为游离移植(136例)与原位移植(2464例)的远期结局,经倾向性评分匹配后比较134例游离移植与2359例原位移植患者。结果显示原位双侧内乳动脉组5年、10年、15年远期生存率显著更高(游离移植 vs 原位移植风险比1.53,95%CI 1.14-2.10,P=.004),但两组因心血管原因再入院及再次血运重建风险无显著差异。
要点
- 第二支内乳动脉原位移植与远期生存改善相关,游离移植对比风险比1.53(95%CI 1.14-2.10,P=.004)。
- 两组因心血管原因再入院和再次血运重建风险无显著差异。
- 匹配后两组术前基线特征和早期不良事件无差异。
核心结论
- 在倾向性匹配的小样本冠状动脉搭桥队列中,第二支内乳动脉采用原位移植与远期生存改善相关,而游离移植则不然。
- 两组远期因心血管原因再入院风险和再次血运重建需求相似。
研究设计与样本
- 研究纳入2600例接受双侧内乳动脉搭桥且第一支内乳动脉以原位方式移植至左前降支的患者。
- 第二支内乳动脉作为游离移植136例,作为原位移植2464例。
- 采用一对多倾向性评分匹配,形成134例第二支游离移植与2359例第二支原位移植的队列。
- 比较早期与远期结局,包括生存、再入院和再次血运重建,随访最长25.8年。
主要发现
- 匹配后两组术前基线特征和早期不良事件无差异。
- 原位双侧内乳动脉组5年、10年、15年远期生存率显著高于游离移植双侧内乳动脉组(风险比1.53;95%CI 1.14-2.10;P=.004)。
- 两组远期因心血管原因再入院风险和再次血运重建需求无显著差异。
关键数值与推荐
- 游离移植双侧内乳动脉 vs 原位双侧内乳动脉的远期生存风险比为1.53(95%CI 1.14-2.10,P=.004)。
- 远期生存比较时间点为5年、10年和15年。
- 随访最长时间为25.8年。
临床怎么用
- 在可行情况下,第二支内乳动脉优先考虑原位移植,或有助于改善远期生存。
- 第二支内乳动脉选择游离移植时,应权衡其对远期生存的可能不利影响。
局限性
- 研究为小样本倾向性匹配队列,游离移植组仅134例。
- 为回顾性观察性设计,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The study objective was to determine the impact on outcome associated with using the second internal thoracic artery as a free compared with an in situ graft among patients who received the first internal thoracic artery as an in situ internal thoracic artery to the left anterior descending artery. METHODS: Among 2600 patients who underwent bilateral internal thoracic artery with an in situ internal thoracic artery to the left anterior descending artery, the second internal thoracic artery was used as a free graft bilateral internal thoracic artery in 136 patients and as an in situ graft (in situ bilateral internal thoracic artery) in 2464 patients. One-to-many propensity score matching was performed to produce a cohort of 134 patients with a second free graft internal thoracic artery matched to 2359 patients with a second in situ internal thoracic artery. Early and long-term outcomes including survival, hospital readmission, and repeat revascularization up to a maximum of 25.8 years were compared. RESULTS: There were no differences between the 2 matched groups' preoperative baseline characteristics and early adverse events. Long-term survival at 5, 10, and 15 years was significantly higher among patients with an in situ bilateral internal thoracic artery compared with patients with a free graft bilateral internal thoracic artery (hazard ratio free graft bilateral internal thoracic artery vs in situ bilateral internal thoracic artery, 1.53; 95% confidence interval, 1.14-2.10; P = .004). However, the long-term risk of readmission to the hospital for cardiovascular reasons and need for repeat revascularization were not significantly different between the 2 matched groups. CONCLUSIONS: In a small, propensity-matched cohort of patients undergoing coronary artery bypass grafting, the use of a second in situ internal thoracic artery was associated with an increase in late survival compared with the use of a second internal thoracic artery as a free graft. However, the risk of late hospital readmission and the need for repeat revascularization were similar.
引用
- Marzouk M, Kalavrouziotis D, Grazioli V, et al. Long-term outcome of the in situ versus free internal thoracic artery as the second arterial graft. J Thorac Cardiovasc Surg. 2020. PMID: 32305200. doi:10.1016/j.jtcvs.2020.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。